Zentalis Pharmaceuticals, Inc. Common Stock
$2.70
▼ 0.05
(-1.82%)
Volume: 1,066,846
· 2026-09-25
Loading…
RSI (14)
🧭 Style Verdicts
🚀
Momentum
13
- 21d momentum -30.6%
- MA aligned bearish
- RSI 25 oversold
🎯
Pullback
72
- RSI 25 near lows
- Near lower Bollinger band
- -21.1% vs 20MA
💎
Value
58
- -61% off 52w high
Scores (0–100) derived from live technical & fundamental metrics. Not investment advice.
📐 Technicals
RSI(14)24.5
MACD-0.059
MA trendBearish
ATR8.34%
21d mom.-30.6%
63d mom.-33.2%
vs 20MA-21.1%
RVOL(20)1.14×
52w low · 1
52w high · 7
-61.1% from 52-week high
20d support 3
· resistance 4
Computed live from daily OHLCV · as of 2026-09-25
🏦 Fundamentals
Market cap$260M
PER—
PBR1.81
PSR—
EPS$-1.47
ROE-97.2%
ROA-64.8%
Dividend yield0.00%
Debt/Equity0.00
EV/EBITDA-1.54
| week | 1M | 3M | 6M | 1Y | YTD |
|---|---|---|---|---|---|
| -13.18% | -30.59% | -33.17% | +1.12% | +77.63% | +97.08% |
Valuation and profitability in USD, latest reported 2026-09-24. Period returns are price-based.
⚖️ AI Bull vs Bear
14d momentum -32.33%, daily vol 3.63%. Zentalis Pharmaceuticals, Inc. Common Stock sits in a bearish regime.
Derived from 14-day momentum and daily volatility on real OHLCV.
🗞 Related News
No recent news.